Optimization of treatment for patients with recurrent cerebral hemispheric ischemic stroke in an acute period
Journal Title: Український неврологічний журнал - Year 2018, Vol 0, Issue 1
Abstract
Objective — to optimize treatment in patients with recurrent cerebral hemispheric ischemic stroke (RCHIS) by comparing the effectiveness of mononeuroprotective, combined neuroprotective and neurometabolic as well as basic therapy in the dynamics of an acute period of the disease. Methods and subjects. An open, comparative, cohort, prospective study that included 86 patients aged 50 to 80 years with RCHIS was conducted. All patients were randomized by sex, age, stroke subtype, lesion focus and concomitant pathology. The first observation group included 41 patients who received citicoline in addition to basic therapy, the second group consisted of 26 patients taking combination of citicoline and Actovegin drugs, and the third group consisted of 19 patients who received only basic therapy (antiplatelet, hypotensive drugs, anticoagulants, statin drugs and symptomatic therapy according to indications). On the 1st and on the 13th day of the acute period, all patients underwent a detailed study of the clinicalneurological status with the assessment of the severity of stroke by stroke scale NIH (National Institutes of Health). Cognitive profile was evaluated by scales: MMSE (MiniMental State Examination, MoCA (Montreal Cognitive Assessment) and FAB (Frontal Assessment Battery), On the 21st day of the acute period of RCHIS, the degree of disability was assessed according to the modified Rankin scale (mRS). Results. In the group of patients taking combination therapy with citicoline and Actovegin was observed a statistically significant difference in the mean score on the NIH, MoCA and MMSE scales in comparison with patients taking mononeuroprotective and basic therapy. The average score by mRS in the patients of the second observation group was 2.27 ± 0.15, which associated with favorable functional outcome of the acute period of the disease. Conclusions. Combined action of drugs citicoline and Actovegin contributed to a more active regression of neurological and cognitive deficits and improved clinical and social outcomes of the acute period of the disease and proved superior to mononeuroprotective and basic therapy.
Authors and Affiliations
Novikova L. V.
Keywords
Related Articles
- EP ID EP292070
- DOI -
- Views 91
- Downloads 0
Nervous system impairment under systemic lupus erythematosus: pathogenesis aspects, prevalence and views on clinical manifestations classification
Systemic lupus erythematosus is an autoimmune disease that involves almost all organ systems. The nervous system in this case is not an exception, which is confirmed by the high prevalence of neurological symptoms in pat...
Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes: modern views on the problem
The article discusses the main aspects of the etiology of mitochondrial disorders, where the key factor is mutations in mitochondrial and nuclear DNA. The most common variants of mutations that cause the development of t...
Current situation in the clinic of motor disorders (on the materials of the International scientific and practical conference, Uzhhorod, April 13 — 14, 2018)
-
Health related quality of life in patients in recovery period of hemispheric ischemic stroke
Objective — to estimate effectiveness of basic programme for secondary prophylaxis in comparison with advanced secondary prophylaxis tactics on health related quality of life outcomes in patients with hemispheric ischemi...
Diagnosis of herpes infection as the part of a comprehensive examination of patients with the oculomotor cranial nerves disorders
Objective — to study the presence of 8 human herpesvirus DNA in the venous blood of patients with oculomotor disorders (OMD) caused by dysfunction of III and/or VI cranial nerves (CN), and the effect of etiotropic treatm...